CIBC World Markets’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $15.3M | Buy |
+283,176
| New | +$13.6M | 0.07% | 178 |
|
|
2025
Q2 | $11.9M | Buy |
256,079
+11,355
| +5% | +$557K | 0.07% | 210 |
|
|
2025
Q1 | $14.9M | Sell |
244,724
-75,221
| -24% | -$4.38M | 0.12% | 131 |
|
|
2024
Q4 | $18.1M | Buy |
319,945
+44,772
| +16% | +$2.5M | 0.11% | 148 |
|
|
2024
Q3 | $14.2M | Buy |
275,173
+13,884
| +5% | +$651K | 0.1% | 153 |
|
|
2024
Q2 | $10.9M | Buy |
261,289
+57,240
| +28% | +$2.56M | 0.07% | 183 |
|
|
2024
Q1 | $11.1M | Sell |
204,049
-667,374
| -77% | -$34M | 0.07% | 188 |
|
|
2023
Q4 | $44.7M | Buy |
871,423
+39,117
| +5% | +$2.05M | 0.24% | 67 |
|
|
2023
Q3 | $48.3M | Buy |
832,306
+586,100
| +238% | +$35.9M | 0.47% | 41 |
|
|
2023
Q2 | $15.7M | Buy |
246,206
+77,843
| +46% | +$5.22M | 0.13% | 127 |
|
|
2023
Q1 | $11.7M | Sell |
168,363
-134,100
| -44% | -$9.46M | 0.19% | 99 |
|
|
2022
Q4 | $21.8M | Buy |
302,463
+160,064
| +112% | +$12.1M | 0.15% | 106 |
|
|
2022
Q3 | $10.1M | Sell |
142,399
-6,231
| -4% | -$452K | 0.14% | 80 |
|
|
2022
Q2 | $11.4M | Sell |
148,630
-299,793
| -67% | -$22.8M | 0.11% | 120 |
|
|
2022
Q1 | $32.7M | Buy |
448,423
+29,812
| +7% | +$2M | 0.26% | 73 |
|
|
2021
Q4 | $26.1M | Sell |
418,611
-82,790
| -17% | -$4.86M | 0.14% | 100 |
|
|
2021
Q3 | $29.7M | Buy |
501,401
+346,295
| +223% | +$22.8M | 0.2% | 87 |
|
|
2021
Q2 | $10.4M | Sell |
155,106
-58,492
| -27% | -$3.81M | 0.07% | 163 |
|
|
2021
Q1 | $13.5M | Sell |
213,598
-202,784
| -49% | -$12.6M | 0.08% | 165 |
|
|
2020
Q4 | $25.8M | Buy |
416,382
+144,947
| +53% | +$8.91M | 0.13% | 123 |
|
|
2020
Q3 | $16.4M | Sell |
271,435
-607,014
| -69% | -$36.5M | 0.16% | 140 |
|
|
2020
Q2 | $51.7M | Buy |
878,449
+635,185
| +261% | +$38M | 0.55% | 44 |
|
|
2020
Q1 | $13.6M | Sell |
243,264
-369,207
| -60% | -$22.6M | 0.17% | 123 |
|
|
2019
Q4 | $39.3M | Buy |
612,471
+21,938
| +4% | +$1.26M | 0.25% | 98 |
|
|
2019
Q3 | $29.9M | Buy |
590,533
+216,774
| +58% | +$10.2M | 0.28% | 93 |
|
|
2019
Q2 | $16.9M | Sell |
373,759
-18,664
| -5% | -$869K | 0.13% | 177 |
|
|
2019
Q1 | $18.7M | Sell |
392,423
-136,944
| -26% | -$6.82M | 0.15% | 145 |
|
|
2018
Q4 | $27.5M | Buy |
529,367
+78,140
| +17% | +$4.2M | 0.26% | 102 |
|
|
2018
Q3 | $28M | Sell |
451,227
-951,492
| -68% | -$56.5M | 0.24% | 108 |
|
|
2018
Q2 | $77.6M | Buy |
1,402,719
+1,100,089
| +364% | +$59.4M | 0.67% | 26 |
|
|
2018
Q1 | $19.1M | Sell |
302,630
-61,748
| -17% | -$3.97M | 0.2% | 112 |
|
|
2017
Q4 | $22.3M | Buy |
364,378
+112,277
| +45% | +$7.02M | 0.16% | 133 |
|
|
2017
Q3 | $16.1M | Buy |
252,101
+19,305
| +8% | +$1.13M | 0.15% | 133 |
|
|
2017
Q2 | $13M | Buy |
232,796
+58,108
| +33% | +$3.16M | 0.14% | 172 |
|
|
2017
Q1 | $9.5M | Sell |
174,688
-439,949
| -72% | -$24.1M | 0.08% | 186 |
|
|
2016
Q4 | $35.9M | Buy |
614,637
+112,800
| +22% | +$6.17M | 0.37% | 65 |
|
|
2016
Q3 | $27.1M | Buy |
+501,837
| New | +$32.2M | 0.51% | 49 |
|
|
2015
Q2 | – | Sell |
-500,000
| Closed | -$32.3M | – | 198 |
|
|
2015
Q1 | $32.3M | Buy |
+500,000
| New | +$31.3M | 1.98% | 18 |
|
Other funds holding BMY
CIBC World Markets's BMY Position: Q4 2025 in Review
CIBC World Markets opened a new position in Bristol-Myers Squibb (BMY) in Q4 2025: 283,176 shares worth $15.3M. The stake represents 0.07% of the portfolio and ranks #178 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in BMY as recently as Q2 2025.
CIBC World Markets first reported a position in BMY in Q1 2015 and has held it in 38 quarters since. The position peaked at $77.6M in Q2 2018. 2,456 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- CIBC World Markets held 283,176 shares of Bristol-Myers Squibb worth $15.3M as of Q4 2025.
- Bristol-Myers Squibb was a new CIBC World Markets position in Q4 2025.
- Bristol-Myers Squibb made up 0.07% of CIBC World Markets's portfolio in Q4 2025, its #178 holding.
- CIBC World Markets first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 38 quarters since.
- CIBC World Markets's Bristol-Myers Squibb position peaked at $77.6M in Q2 2018.
- 2,456 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.